TWI225789B - Compositions inhibiting muscle atrophy - Google Patents

Compositions inhibiting muscle atrophy Download PDF

Info

Publication number
TWI225789B
TWI225789B TW089118696A TW89118696A TWI225789B TW I225789 B TWI225789 B TW I225789B TW 089118696 A TW089118696 A TW 089118696A TW 89118696 A TW89118696 A TW 89118696A TW I225789 B TWI225789 B TW I225789B
Authority
TW
Taiwan
Prior art keywords
composition
atrophy
muscle atrophy
weight
inhibiting
Prior art date
Application number
TW089118696A
Other languages
English (en)
Chinese (zh)
Inventor
Keitaro Matsumoto
Takae Yanagisawa
Masao Sakurai
Koji Okamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of TWI225789B publication Critical patent/TWI225789B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
TW089118696A 1999-09-17 2000-09-13 Compositions inhibiting muscle atrophy TWI225789B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26375799A JP2001089387A (ja) 1999-09-17 1999-09-17 筋萎縮抑制組成物

Publications (1)

Publication Number Publication Date
TWI225789B true TWI225789B (en) 2005-01-01

Family

ID=17393869

Family Applications (1)

Application Number Title Priority Date Filing Date
TW089118696A TWI225789B (en) 1999-09-17 2000-09-13 Compositions inhibiting muscle atrophy

Country Status (4)

Country Link
JP (1) JP2001089387A (ja)
KR (2) KR100625508B1 (ja)
TW (1) TWI225789B (ja)
WO (1) WO2001021186A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004250390A (ja) * 2003-02-21 2004-09-09 Taisho Pharmaceut Co Ltd 鉄化合物配合内服液剤
JP5275537B2 (ja) * 2004-08-24 2013-08-28 学校法人日本医科大学 筋肉の酸化ストレス由来疾患予防経口剤
JP2006328031A (ja) * 2005-05-30 2006-12-07 Asahi Breweries Ltd 筋繊維タイプ移行抑制剤
US20090162457A1 (en) 2005-10-26 2009-06-25 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
KR101473017B1 (ko) * 2006-07-05 2014-12-15 카오카부시키가이샤 노화 억제제
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
JP5507802B2 (ja) * 2006-08-10 2014-05-28 花王株式会社 筋肉老化抑制剤
WO2011007866A1 (ja) * 2009-07-16 2011-01-20 国立大学法人名古屋大学 筋強直性ジストロフィー治療薬
JP2013126951A (ja) * 2010-03-01 2013-06-27 Kyushu Univ 筋萎縮阻害剤
JP6395350B2 (ja) 2013-03-28 2018-09-26 雪印メグミルク株式会社 筋萎縮防止剤
CN110234334B (zh) * 2016-12-05 2024-02-06 大塚制药株式会社 肌肉萎缩抑制组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6116982A (ja) * 1984-07-03 1986-01-24 Kikkoman Corp 抗酸化剤
JP3521155B2 (ja) * 1993-12-06 2004-04-19 ニッカウヰスキー株式会社 果実ポリフェノールの製造方法

Also Published As

Publication number Publication date
KR20060057030A (ko) 2006-05-25
KR100625508B1 (ko) 2006-09-20
WO2001021186A1 (fr) 2001-03-29
KR20020042678A (ko) 2002-06-05
JP2001089387A (ja) 2001-04-03

Similar Documents

Publication Publication Date Title
KR100795327B1 (ko) 근장력 증강제
KR20080030633A (ko) 스트레스의 치료 또는 처치방법
TWI225789B (en) Compositions inhibiting muscle atrophy
JP2016506381A (ja) シクロデキストリンを含むカテキン生体利用率増進剤
JP2006083151A (ja) 骨粗鬆症予防、改善用組成物
KR100597235B1 (ko) 오미자 추출물을 유효성분으로 함유하는 관절염 예방 및치료용 조성물
WO2005094860A1 (ja) 末梢血流改善剤
JP4812222B2 (ja) ミネラル吸収促進剤
US20080020067A1 (en) Skin Moisturizer
EP1656943A1 (en) Extract from plant of japanese parsley family and process for producing the same
JP2005185188A (ja) アセロラ処理物およびｌ−カルニチン含有組成物
KR20130097537A (ko) 강황, 석창포, 원지의 열수추출물의 혼합물을 유효성분으로 포함하는 인지력 및 기억력 향상용 조성물
JP3297673B2 (ja) ペピノ抽出物を含有する血中アルコール濃度低下用組成物及びその製造方法
JP6418456B2 (ja) 尿酸排泄促進組成物
JP2005298429A (ja) 血管内皮型一酸化窒素合成酵素活性促進剤
JP2006182654A (ja) 体脂肪の蓄積抑制または低減剤
JP2008074734A (ja) インスリン抵抗性改善剤
KR101757841B1 (ko) 바이칼린-아연착염을 포함하는 비만억제용 조성물
JP7179025B2 (ja) 後発酵茶由来の新規なケンペロール系化合物を含む抗炎症組成物
KR20110051545A (ko) 오디 발효 추출물을 유효성분으로 함유하는 통풍의 예방 또는 치료용 조성물
JP6981641B2 (ja) Ｐｄｅ５活性阻害剤
KR20110051541A (ko) 흑마늘 추출물을 유효성분으로 함유하는 통풍의 예방 또는 치료용 조성물
JP2012236793A (ja) Ａｍｐｋ活性化剤
KR20100104275A (ko) 간기능 개선용 조성물 및 이를 포함하는 식품 조성물
KR20050119488A (ko) 퇴행성 관절염 예방 및 치료용 조성물